Global Forum on Stem Cell Biology & Regenerative Medicine
StemRegen 2027
Researchriser Presentation Event
Theme: Bridging Global Innovation in Cellular Reprogramming & Translational Therapies
About StemRegen 2027
StemRegen 2027 brings together cellular biologists, tissue engineers, clinicians, academic scholars, and biotech industry representatives specializing in stem cell biology and regenerative medicine. Taking place in San Francisco, USA, the forum serves as a technical platform to present current research data, discuss laboratory findings, and analyze engineering methods underlying modern cell therapies.
By maintaining an international registry of presenters, StemRegen 2027 focuses on the exchange of structural methods, multi-laboratory project collaboration, and the step-by-step transition of basic cellular research into verified clinical trial models.
Forum Highlights
Learning Deliverables
Cellular Diagnostics
Evaluate recent pluripotency frameworks, single-cell sequencing models, and high-throughput diagnostic tools directly with global research peers. Refine biological assays and optimize evidence-based cell line validation.
Global Partnerships
Drive international cross-sector collaborations and standardization policies to upgrade bio-banking and manufacturing delivery systems worldwide. Focus on establishing multi-laboratory networks.
Bench to Bedside
Bring complex, peer-reviewed stem cell datasets and longitudinal clinical trial results into day-to-day therapeutic workflows. Translate abstract cellular analytics into practical, hands-on methodology.
Featured Scientific Tracks
Cellular Reprogramming
iPSCs, direct reprogramming, epigenetic modification, pluripotency mechanisms, and differentiation pathways. High-purity isolation models.
Learn MoreTissue Engineering
3D Bioprinting, organoid systems, biomaterials, structural scaffolds, and tissue vascularization strategies for functional repair.
Learn MoreTranslational Therapies
Clinical trial dataset monitoring, cell-based immunotherapies, automated tissue repair fields, and clinical pipeline assessments.
Learn MoreGene Editing & CRISPR
In vivo cutting mechanics, safety profiles, off-target tracking arrays, and therapeutic gene delivery systems.
Learn MoreRegulatory & Logistics
FDA/EMA compliance criteria, scalable bio-manufacturing infrastructures, and global bio-banking standardization frameworks.
Learn MoreCall for Abstracts
StemRegen 2027 invites researchers, laboratory principal investigators, clinicians, and biotech developers to submit original laboratory data, translational observations, and case studies.
All submissions will undergo rigorous peer review. Accepted abstracts will be assigned to podium presentation slots or digital e-poster gallery channels.
Submit Abstract DataScientific Schedule Overview
Passes & Fee Tiers
| Registration Tier | Early Bird Until July 27, 2026 |
Mid-Term Until Sept 27, 2026 |
Final Until Jan 27, 2027 |
|---|---|---|---|
| Speaker / Oral Presentation | $749 | $899 | $1049 |
| Delegate / Listener Access | $749 | $799 | $949 |
| Poster Presentation | $649 | $749 | $899 |
| Student / Resident Pass | $449 | $549 | $649 |
| Virtual E-Poster Track | $149 | $199 | $249 |